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Received 26 April 2016; revised 17 May 2016; accepted 17 May 2016AbstractObjective: To investigate the membrane localization function of the CX26 protein when its 86th amino acid is Thr, Ser or Arg, and its relations to
deafness.
Methods: CX26-GFP protein with either Thr, Ser or Arg as the 86th amino acid was expressed in mouse SGN cells via the GFP fusion type lenti-
virus expression system. The membrane localization of the fusion protein was observed under a fluorescence microscope.
Results: The mutated protein of CX26 T86S was localized to cell membrane and form gap conjunction structures, showing no difference to the
wild type CX26 protein (with Thr as the 86th amino acid). However, the gap conjunction structure disappeared when the mutation was CX26
T86A.
Conclusion: These results indicate that the CX26 T86R mutation may be a cause of hearing loss, but CX26 T86S as a non-pathogenic poly-
morphism mutation does not affect functions of the CX26 protein. The results are in accordance with the results of clinical screening.
Copyright © 2016, PLA General Hospital Department of Otolaryngology Head and Neck Surgery. Production and hosting by Elsevier
(Singapore) Pte Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Hereditary hearing loss is a common human birth defect
with an incidence of about 1 in 700e1000 (Li et al., 2015) new
births, over half of the which are a result of hereditary hearing
disabilities. GJB2 gene mutations are related to 36.9% of
sensory neural hearing loss (SNHL) among children (Ouyang
et al., 2009), while the CX26 e the GJB2-coded protein e is* Corresponding author.
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Pte Ltd. This is an open access article under the CC BY-NC-ND license (http://crinvolved in the transportation of potassium and serves as the
connexon, key to maintaining the balance and stability of inner
ear ions. By far, more than 150 mutation sites in the GJB2
genes have been discovered (http://davinci.crg.es/deafness)
(Wei et al., 2014; Zelante et al., 1997; Petersen and Willems,
2006; Choi, 2009; Van Laer et al., 1999; Welch et al., 2007;
Yan et al., 2006).
The 86th amino acid of CX26 displays a certain degree of
polymorphism. Many reports consider the 86th amino acid of
the wild-type CX26 being Threonine (Thr), whose corre-
sponding pathogenic mutations is CX26 T86R
(GJB2c.257C > G) (Wei et al., 2014; Choi, 2009). CX26 T86S
(GJB2c.257-258CG>GC), a form of non-pathogenicmutation,
has no clinical evidence to establish causal link to hereditary
hearing loss (Dai et al., 2009; Hilgert et al., 2009). As a result,gy Head and Neck Surgery. Production and hosting by Elsevier (Singapore)
eativecommons.org/licenses/by-nc-nd/4.0/).
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AAP35378; ID AAD21314) in the EBI database (Fig. 1) (Lee
et al., 1992). However, by far there is no systematic study
about the biological function of CX26 proteins inwhich the 86th
amino acid is Thr, Ser or Arg (whose codons are ACG, AGC or
AGG) respectively. This research used GFP infused lenti virus
system to study the biological function of the polymorphism of
CX26's 86th amino acid (Thr, Ser or Arg), which to some extent
helped explain the mechanism behind the relation between
polymorphism of the amino acid and hereditary hearing loss.
2. Results2.1. Comparison of non-pathogenic polymorphism of
CX26's 86th amino acid using Peiking University's
online biological information analysis platform (www.
abc.pku.cn)We analyzed the similarity of CDS sequences of the two
normal GJB2 genes (EBIID AAP35378; ID AAD21314)
submitted by previous studies to the EBI database. We found
that the 257-258th base pairs of the two sequences were CG or
GC (whose codons are ACG or AGC (256-258)) and the
corresponding amino acids are Thr and Ser. This in turn helped
decide the polymorphism of CX26's 86th amino acids (Fig. 1).2.2. Analysis of the biological function of CX26 proteinsBased on previous research that studied the two non-
pathogenic forms of the 86th amino acid, namely Thr and
Ser, of normal CX26s and the pathogenic mutation of Arg, this
study successfully constructed a series of CX26-GFP infused
protein lenti-virus. The packaged lenti-virus was used to infect
prime SCN cells of mice and sub-cellular localization was
examined after 48 h using fluorescent microscopy. The results
are shown in Fig. 2.
The far left pictures in Fig. 2 show the foci-pattern of CX 26-
GFP in the SGN cells with the 86th amino acid being Thr,
indicating that the protein was identified in cell membrane and
formed conjunction structures. When the 86th amino acid was
Ser (middle pictures in Fig. 2), sub-cellular localization showed
a similar pattern. But when the 86th amino acid was Arg (right
side pictures in Fig. 2), the mutation resulted in the mutated
proteins unable to be identified in cell membrane but diffused
evenly in cytoplasm, indicating a high possibility that the mu-
tation may be a potential cause of hereditary hearing loss.Fig. 1. Polymorphism analysis of the GJB2 gene and the sequence of their
corresponding CX26 proteins. Top: Differences in polymorphism of the
257-258th base pairs in GJB2. Bottom: Polymorphism comparison between
the 86th amino acid of CX26 proteins.3. Discussion
This study analyzed sub-cellular localization of different
CX26-GFP proteins. When the 86th amino acid was Thr or Ser,
the CX26 protein was identified in cell membrane and formed
gap junction structure. But when the 86th amino acid became
Arg, themutated proteinwas not identified in cellmembrane but
found diffused evenly in cytoplasm. Such phenomenon is
similar to results of studies on 293T celline (Wei et al., 2014;
Choi, 2009). This research for the first time proves this phe-
nomenon in neural cells in the inner ear of mice while providing
evidence that has been previously lacked with regard to the
biological function of the 86th Ser of CX26 protein, which lends
theoretical basis in support of non-pathogenic mutations in
clinical screening. An comparative analysis of amino acid
structures shows that Thr and Ser are hydrophobic amino acids
which share similar structures with side chains of similar
lengths and whose function group exhibit no more difference
than a single methyl. This leads us to hypothesize that when the
86th Thr is replaced with Ser, the impact on CX26's structure is
negligible. As a result, the claim that the 86th Ser is a non-
pathogenic mutations can be reasonably explained. On the
contrary, if the 86th amino acid of the CX26 protein becomes
Arg, the likely result is a change of the protein's structure due to
the fact that Arg's polarity is far greater that of Thr and it tends to
have longer side chains. One of the major changes is loss of
function caused by the formation of an effective protein hex-
amers, which to some extent helps explain the mechanism of
CX26 T86A as a deafness-inducing mutation.
Polymorphismof the86thaminoacid inCX26hasbeenwidely
discussed in many studies on the screening of deadness-inducing
genes around the world. Polymorphism exists in the form of Thr,
Ser and Arg whose corresponding cordons are ACG, AGC and
AGG (GJB2 256-258bp) respectively. Research results have
demonstrated biological malfunction of the CX26 protein when
the86th amino acid ismutated intoArg.Theconclusioncoincides
with results of many studies about GJB2c.257C > G p.T86R.
Another finding of this study is that when the 86th amino acid
becomes Ser rather than Thr, the function of CX26 changes little
(Fig. 2). Clinical screening data have also proved such a finding,
i.e.GJB2c.257-258GC>CGp.S86Tisapolymorphismmutation
that does not cause hearing loss. However, it is worth noting that
some studies believe that the polymorphismofCX26 is a result of
mutation of the 86th Ser into Thr (Liu et al., 2012; Zheng et al.,
2000). Despite that these two amino acids do not affect the
biological function of the CX26 protein, the statement
(GJB2c.257-258GC>CGp.S86T) contradictswith the other one
about pathogenic mutations (the GJB2c.257C>G p.T86R) (Wei
et al., 2014; Choi, 2009; Dai et al., 2009), while the latter tacitly
regards the 86th amino acid of the CX26 protein as Thr while the
former treats it as Ser, leading to confusion about its poly-
morphism and statistical margins of error. The authors suggest
that the 86th amino acid of thewild typeCX26be treated asThr in
general and the statement (GJB2 256-258 CG > GCp.T86S) is
preferred in the description of the non-pathogenicmutation of Ser
to ensure that a standardwild type sequence is adopted as thebasis
for data analysis in the screening of the polymorphismof the 86th
Fig. 2. Sub-cellular localization of CX26-GFP proteins whose 86th amid acid is Thr, Ser or Arg. The bottom row shows magnified images in the corresponding
boxed in the top row. Arrowhead point to conjunctional structures formed by CX26-GFPp86Thr (left) and CX26-GFPp86Ser (middle) in cell membrane. The far
right column shows CX26-GFPp86Arg failing to locate in cell membrane and form conjunctional structures.
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technique to conduct an effective assessment of the biological
function of the GJB2 gene with polymorphism. By providing
strong empirical evidence for pathogenic analysis at rare sites of
GJB2 mutations, our study offers clear theoretical guidance for
explaining the pathogenicmechanism ofGJB2 rare-sitemutation
carriers during clinical screening.
4. Conclusion
To sum up, the study analyzed for the first time the poly-
morphism of the 86th amino acid in the CX26 protein and
tested their cellular function through techniques of molecular
biology. The findings show that only when the 86th amino acid
mutates into Arg does the CX26 protein lose function, which
coincides with empirical results of clinical screening. In
addition, the study explored a technical method that effec-
tively identified membrane localization of the mutational
CX26 protein, which in turn helped provide diagnostic advice
for mutation carriers on the incidence of hereditary deafness.
5. Material and methods5.1. Sequence similarity analysisUsing Peiking University's online biological information
platform (www.abc.pku.cn), the similarity of CDS sequencesof two normal GJB2 genes (EBIID AAP35378; ID
AAD21314) submitted by previous studies to the EBI database
were analyzed.5.2. Vector construction and viral packingThe pWPXLD lentiviral vectors were used. The GJB2 gene
was cloned by RTePCR from total RNA of the human
WI38 cells line. The amplified PCR product was inserted into
the PmeI/BamHI or BamHI/EcoRI sites of the pWPXLD
vector, and then fused with the EGFP (enhanced green fluo-
rescent protein) gene. Lentiviruses were packed using HEK-
293T cells co-transfection with the plasmid of pWPXLD,
pPAX and pMD-2G. Lentivirus supernatant was collected
together at 48 h, 72 h and 96 h respectively after transfection
and concentrated by ultrafiltration with 100 kD membrane.
The concentrated viral liquid was aliquoted into 50 ul in each
1.5 ml EP tube for storage at 80 C for preparation.5.3. SGN cells infection and detection of GJB2-GFP
protein localizationPrimary SGN cells were isolated from neonatal mice as
previously described. Concentrated virus was then diluted with
culturemedium and applied to SGN cells for 24 hwith change of
the culture medium. Images were taken under a confocal laser-
scanning microscope (Olympus FV1000) at 72 h after infection.
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